User profiles for Antoine Daridon
Antoine Daridonbusiness development & Marketing Manager Verified email at metrolab.com Cited by 4734 |
Microfluidic device for single-cell analysis
…, YH Liao, K Farrell, ID Manger, A Daridon - Analytical …, 2003 - ACS Publications
We have developed a novel microfluidic device constructed from poly(dimethylsiloxane)
using multilayer soft lithography technology for the analysis of single cells. The microfluidic …
using multilayer soft lithography technology for the analysis of single cells. The microfluidic …
Design and optimization of coin-shaped microreactor chips for PET radiopharmaceutical synthesis
…, D Stout, J Shu, J Huang, A Daridon… - Journal of Nuclear …, 2010 - Soc Nuclear Med
An integrated elastomeric microfluidic device, with a footprint the size of a postage stamp,
has been designed and optimized for multistep radiosynthesis of PET tracers. Methods: The …
has been designed and optimized for multistep radiosynthesis of PET tracers. Methods: The …
Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics
Microreactor technology has shown potential for optimizing synthetic efficiency, particularly
in preparing sensitive compounds. We achieved the synthesis of an [ 18 F]fluoride-…
in preparing sensitive compounds. We achieved the synthesis of an [ 18 F]fluoride-…
Multi-layer microfluidic glass chips for microanalytical applications
A Daridon, V Fascio, J Lichtenberg, R Wütrich… - Fresenius' journal of …, 2001 - Springer
A new, versatile architecture is presented for microfluidic devices made entirely from glass,
for use with reagents which would prove highly corrosive for silicon. Chips consist of three …
for use with reagents which would prove highly corrosive for silicon. Chips consist of three …
Chemical sensing using an integrated microfluidic system based on the Berthelot reaction
A Daridon, M Sequeira, G Pennarun-Thomas… - Sensors and Actuators B …, 2001 - Elsevier
The Berthelot reaction is a well-established colorimetric method for the determination of
ammonia. It has been investigated with the particular aim of incorporating it into a simple, …
ammonia. It has been investigated with the particular aim of incorporating it into a simple, …
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific …
…, N Shah, F McCormick, S Willis, A Daridon… - Leukemia, 2009 - nature.com
ABL is the main target of several tyrosine kinase inhibitors used in the treatment of chronic
myeloid leukemia (CML) patients. ABL tyrosine kinase domain (TKD) point mutations are the …
myeloid leukemia (CML) patients. ABL tyrosine kinase domain (TKD) point mutations are the …
Progress in the realisation of an autonomous environmental monitoring device for ammonia
Progress in the development of a micro-fluidic system for colorimetric monitoring of ammonia
in drinking and wastewater is described. The ultimate goal is to have a miniaturised …
in drinking and wastewater is described. The ultimate goal is to have a miniaturised …
[HTML][HTML] Flow optimization study of a batch microfluidics PET tracer synthesizing device
…, R Miraghaie, RM Van Dam, J Huang, A Daridon… - Biomedical …, 2011 - Springer
We present numerical modeling and experimental studies of flow optimization inside a batch
microfluidic micro-reactor used for synthesis of human-scale doses of Positron Emission …
microfluidic micro-reactor used for synthesis of human-scale doses of Positron Emission …
Microfluidic chemical reaction circuits
… Quake, Stanford, CA (US); Hsian-rong Tseng, I os Angeles, CA (US); Paul Wyatt,
Tipperary (IE); Antoine Daridon, Mont-Sur-Rolle (CH) (73) Assignees: Fluidigm Corporation …
Tipperary (IE); Antoine Daridon, Mont-Sur-Rolle (CH) (73) Assignees: Fluidigm Corporation …
Absolute Quantitative Detection of Abl Tyrosine Kinase Domain Mutations Using a Novel Microfluidic Platform and Allele-Specific PCR.
V Oehler, S Ananthnarayan, F McCormick, A Daridon… - 2005 - ashpublications.org
Point mutations in the Abl tyrosine kinase domain are the main mechanism of secondary
resistance to imatinib mesylate (IM) therapy in chronic myeloid leukemia (CML) patients. …
resistance to imatinib mesylate (IM) therapy in chronic myeloid leukemia (CML) patients. …